Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02759588
Title GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Genelux Corporation
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Gynecologic Oncology Associates Newport Beach California 92663 United States Details
AdventHealth Cancer Institute Orlando Florida 32804 United States Details
*Shaded cells indicate that there was no data available from for the field